These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28413843)

  • 21. Older adults with difficulty swallowing oral medicines: a systematic review of the literature.
    Mc Gillicuddy A; Crean AM; Sahm LJ
    Eur J Clin Pharmacol; 2016 Feb; 72(2):141-51. PubMed ID: 26573594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory perspectives on acceptability testing of dosage forms in children.
    Kozarewicz P
    Int J Pharm; 2014 Aug; 469(2):245-8. PubMed ID: 24704104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry Survey on Current Practices in the Assessment of Palatability and Swallowability in the Development of Pediatric Oral Dosage Forms.
    Thompson CA; Lombardi DP; Sjostedt P; Squires LA
    Ther Innov Regul Sci; 2013 Sep; 47(5):542-549. PubMed ID: 30235578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral dosage forms for children: acceptability and palatability].
    Kojima J
    Yakugaku Zasshi; 2015; 135(2):245-7. PubMed ID: 25747220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods of administering oral formulations and child acceptability.
    van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
    Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ease of oral administration and owner-perceived acceptability of triglyceride oil, dissolving thin film strip, and gelatin capsule formulations to healthy cats.
    Traas AM; Fleck T; Ellings A; Mahabir S; Stuebner K; Brown DC; Durso D; DiGregorio M; Bode L; Kievit KI; McCall R
    Am J Vet Res; 2010 Jun; 71(6):610-4. PubMed ID: 20513174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient acceptability of 3D printed medicines.
    Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
    Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Acceptability' of a new oral suspension formulation of mercaptopurine in children with acute lymphoblastic leukaemia.
    Mulla H; Buck H; Price L; Parry A; Bell G; Skinner R
    J Oncol Pharm Pract; 2016 Jun; 22(3):387-95. PubMed ID: 25837624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor formulation information in published pediatric drug trials.
    Standing JF; Khaki ZF; Wong IC
    Pediatrics; 2005 Oct; 116(4):e559-62. PubMed ID: 16199684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardised evaluation of medicine acceptability in paediatric population: reliability of a model.
    Vallet T; Ruiz F; Lavarde M; Pensé-Lhéritier AM; Aoussat A
    J Pharm Pharmacol; 2018 Jan; 70(1):42-50. PubMed ID: 29072321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians.
    Ruiz F; Vallet T; Dufaÿ Wojcicki A; Belissa É; Fontan JE; de Pontual L; Nathanson S; Chevallier A; Laribe-Caget S; Boudy V
    PLoS One; 2019; 14(8):e0221261. PubMed ID: 31430323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.
    Martir J; Flanagan T; Mann J; Fotaki N
    J Pharm Pharmacol; 2017 Apr; 69(4):384-397. PubMed ID: 27704550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral transmucosal drug delivery for pediatric use.
    Lam JK; Xu Y; Worsley A; Wong IC
    Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability of orodispersible films for delivery of medicines to infants and preschool children.
    Orlu M; Ranmal SR; Sheng Y; Tuleu C; Seddon P
    Drug Deliv; 2017 Nov; 24(1):1243-1248. PubMed ID: 28856931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of tribology in assessing texture perception of oral liquid medicines.
    Batchelor H; Venables R; Marriott J; Mills T
    Int J Pharm; 2015 Feb; 479(2):277-81. PubMed ID: 25575471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.